Commitment to Patient-Centered Care
“I am committed to making sure you or your loved one receive the best addiction care available; care that is grounded in science with no judgement, moralizing, or unnecessary steps.”
The addictive diseases are the largest preventable cause of death in the world. Like other chronic diseases such as diabetes and hypertension, treatment of addictions requires a wide range of tools including life-style change, behavioral counseling, and life-saving medications. Recent medical advances have brought to the forefront new tools with which to treat addictions. The Addiction Medicine program at Hennepin County Medical Center provides the best available treatments for the addictive diseases. Through our ongoing commitment to patient care and research, we combine medical innovation with outstanding clinical skills and have become leaders in addiction treatment.
- Bart G, Lenz S, Straka RJ, Brundage RC. Ethnic and genetic factors in methadone pharmacokinetics: a population pharmacokinetic study. Drug Alcohol Depend 2014;145:185-193.
- Pylkas A and Bart G. Prescribing controlled substances during a prescription drug epidemic. Neurol Clin Pract, 2014;4:99-105.
- Bart G. Emerging drug problems in Asia. J Food Drug Anal 2013;21:S19-S20
- Bart G. Collaborative addiction research in the United States and Asia. J Food Drug Anal 2013;21:S106-S108.
- Bart G.Maintenance medication for opiate addiction: the foundation of recovery. J Addict Dis. 2012;31(3):207–225.
- University of Minnesota, Minneapolis, MN, USA
- Internal Medicine, Hennepin Healthcare, Minneapolis, MN, USA
- American Society of Addiction Medicine
- College on Problems of Drug Dependence
- American College of Physicians
- Board certification, Addiction Medicine, American Board of Addiction Medicine
- Board certification, Internal Medicine, American Board of Internal Medicine
- Principal investigator, NorthStar Node of the Clinical Trials Network (NIH-NIDA UG1DA040316)
- Principal Investigator, Population Pharmacokinetics: Methadone-Antiretroviral Interactions in Vietnam (NIH-NIDA R01DA040510)
- Co-Investigator, Buprenorphine to Improve HIV Care Engagement and Outcomes: A Randomized Trial (NIH-NIDA R01DA037441)
- Technical Assistance, US Substance Abuse and Mental Health Services Administration, addiction work-force capacity building efforts in Vietnam (more than 75 weeks in-country experience)
- Member of the Graduate Faculty, Department of Pharmacology, University of Minnesota
- Founding president, Minnesota Society of Addiction Medicine
- Board of Directors, American Society of Addiction Medicine (elected member)
- Distinguished Fellow, American Society of Addiction Medicine
- Fellow, American College of Physicians
“I have devoted my career to the improvement of care for those with addiction at the local, national, and international level. I spend my remaining time outside of work running, listening to old school punk rock, and with my incredible wife and children.”